학술논문
Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran
Document Type
Article
Author
Source
In The American Journal of Medicine May 2022 135(5):595-602
Subject
Language
ISSN
0002-9343